Gene transcription through Myc family members in eukaryotic cells

Japanese Journal of Pharmacology

Volumn 80, Issue 2, 1999, Pages 103-109

  Kuramoto, Nobuyuki ^a   Ogita, Kiyokazu ^a   Yoneda, Yukio ^a,b  

^a SETSUNAN UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

c Myc family protein; DNA binding; DNA topology; E box element; Transcription factor

Indexed keywords

MAGNESIUM ION; NUCLEAR PROTEIN; POLYAMINE; PURINE; PYRIMIDINE;

ANIMAL TISSUE; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA BINDING; EUKARYOTIC CELL; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; ONCOGENE MYC; REVIEW;

EID: 0032777098     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.80.103     Document Type: Review

References (28)

1. Spencer CA and Groudine M: Control of c-myc regulation in normal and neoplastic cells. Adv Cancer Res 56, 1-48 (1991)
2. Freytag SO: Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1. Mol Cell Biol 8, 1614-1624 (1988)
3. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128 (1992)
4. Ayer DE and Eisenman RN: A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev 7, 2110-2119 (1993)
5. Wittig B, Wolfl S, Dorbic T, Vahrson W and Rich A: Transcription of human c-myc in permeabilized nuclei is associated with formation of Z-DNA in three discrete regions of the gene. EMBO J 11, 4653-4663 (1992)
6. Kinniburgh AJ, Firulli AB and Kolluri R: DNA triplexes and regulation of the c-myc gene. Gene 149, 93-100 (1994)
7. Thomas T, Gallo MA, Klinge CM and Thomas TJ: Polyamine-mediated conformational perturbations in DNA alter the binding of estrogen receptor to poly(dG-m5dC).poly(dG-m5dC) and a plasmid containing the estrogen response element. J Steroid Biochem Mol Biol 54, 89-99 (1995)
8. Herbert A, Alfken J, Kim YG, Mian IS, Nishikura K and Rich A: A Z-DNA binding domain present in the human editing enzyme, double-stranded RNA adenosine deaminase. Proc Natl Acad Sci USA 94, 8421-8426 (1997)
9. Guieysse AL, Praseuth D and Helene C: Identification of a triplex DNA-binding protein from human cells. J Mol Biol 267, 289-298 (1997)
10. Musso M, Nelson LD and Van Dyke MW: Characterization of purine-motif triplex DNA-binding proteins in HeLa extracts. Biochemistry 37, 3086-3095 (1998)
11. Pulverer BJ, Fisher C, Vousden K, Littlewood T, Evan G and Woodgett JR: Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene 9, 59-70 (1994)
12. Albert T, Urlbauer B, Kohlhuber F, Hammersen B and Eick D: Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines. Oncogene 9, 759-763 (1994)
13. Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI and Land H: Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 72, 233-245 (1993)
14. Larsson LG, Bahram F, Burkhardt H and Luscher B: Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-931 monoblasts and F9 teratocarcinoma cells. Oncogene 15, 737-748 (1997)
15. Queva C, Hurlin PJ, Foley KP and Eisenman RN: Sequential expression of the MAD family of transcriptional repressor during differentiation and development. Oncogene 16, 967-977 (1998)
16. Hann SR, Dixit M, Sears RC and Sealy L: The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. Genes Dev 8, 2441-2452 (1994)
17. Spotts GD, Patel SV, Xiao Q and Hann SR: Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol Cell Biol 17, 1459-1468 (1997)
18. Bousset K, Henriksson M, Luscher-Firzlaff JM, Litchfield DW and Luscher B: Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers. Oncogene 12, 3211-3220 (1993)
19. Billaud M, Isselbacher KJ and Bernards R: A dominant-negative mutant of Max that inhibits sequence-specific DNA binding by Myc proteins. Proc Natl Acad Sci USA 90, 2739-2743 (1993)
20. Shrivastava A, Saleque S, Kalpana GV, Artandi S, Goff SP and Calame K: Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science 262, 1889-1892 (1993)
21. Schneider A, Peukert K, Eilers M and Hanel F: Association of Myc with the zinc-finger protein Miz-1 defines a novel pathway for gene regulation by Myc. Curr Top Microbiol Immunol 224, 137-146 (1997)
22. Bao J and Zervos AS: Isolation and characterization of Nmi, a novel partner of Myc proteins. Oncogene 12, 2171-2176 (1996)
23. Sakamuro D, Elliott KJ, Wechsler-Reya R and Prendergast GC: BINI is a novel MYC-interacting protein with features of a tumour suppressor. Nat Genet 14, 69-77 (1996)
24. Taira T, Maeda J, Onishi T, Kitaura H, Yoshida S, Kato H, Ikeda M, Tamai K, Iguchi-Ariga SM and Ariga H: AMY-1, a novel C-MYC binding protein that stimulates transcription activity of C-MYC. Genes Cells 3, 549-565 (1998)
25. Fisher DE, Parent LA and Sharp PA: Myc/Max and other helix-loop-helix/leucine zipper proteins bend DNA toward the minor groove. Proc Natl Acad Sci USA 89, 11779-11793 (1992)
26. Durand R, Job C, Zarling DA, Teissere M, Jovin TM and Job D: Comparative transcription of right- and left-handed poly-[d(G-C)] by wheat germ RNA polymerase II. EMBO J 2, 1707-1714 (1983)
27. Ogita K, Amizuka T, Azuma Y and Yoneda Y: Differentiation by magnesium ions of affinities of nuclear proteins for consensus core nucleotide element of the transcription factor c-Myc in murine brain. Neurochem Res 21, 201-209 (1996)
28. Herbert AG and Rich A: A method to identify and characterize Z-DNA binding proteins using a linear oligodeoxynucleotide. Nucleic Acids Res 21, 2669-2672 (1993)